Back
Crinetics Pharmaceuticals, Inc. Stock Predictions
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Sell
47
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$53.20
Seasonality Move:
2.14%
7 Day Trial
ALL ACCESS PASS
$
7
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assetsCrinetics Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Crinetics Pharmaceuticals, Inc. has on average historically risen by 19.5% based on the past 7 years of stock performance.
-
Crinetics Pharmaceuticals, Inc. has risen higher in 6 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 85.71%
-
Is Crinetics Pharmaceuticals, Inc. Stock Undervalued?The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $54.95. The Score for CRNX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Crinetics Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Crinetics Pharmaceuticals, Inc. has on average historically risen by 19.5% based on the past 7 years of stock performance.
Crinetics Pharmaceuticals, Inc. Stock Rating
Sell
47
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. overpriced?
-
Crinetics Pharmaceuticals, Inc. has risen higher in 6 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 85.71%
Crinetics Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
crinetics.com
52-Week Data
52-Week High:
57.99
52-Week Low:
24.10
Prediction Charts
Market Cap:
5.5B
Price in USD:
54.95
Volume:
1.3M
Beta:
0.68
Technical Analysis
SMA50:
47.99
SMA100:
43.80
SMA200:
37.18
52-Wk Change:
42.17%
Stock Predictions
-
Is Crinetics Pharmaceuticals, Inc. stock public?Yes, Crinetics Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Crinetics Pharmaceuticals, Inc. stock quote today?The Crinetics Pharmaceuticals, Inc. stock price is 54.95 USD today.
-
How to buy Crinetics Pharmaceuticals, Inc. stock online?You can buy Crinetics Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-2 | 46.62 | 46.73 | 47.05 | 45.51 |
| Jan-5 | 55.00 | 48.18 | 57.99 | 46.86 |
| Jan-6 | 47.40 | 45.95 | 48.25 | 43.40 |
| Jan-7 | 51.24 | 53.34 | 53.97 | 49.72 |
| Jan-8 | 53.30 | 53.24 | 54.54 | 52.15 |
| Jan-9 | 53.52 | 53.25 | 56.13 | 53.17 |
| Jan-12 | 54.10 | 55.35 | 55.76 | 51.61 |
| Jan-13 | 55.31 | 54.31 | 56.23 | 54.15 |
| Jan-14 | 54.12 | 55.42 | 56.07 | 53.45 |
| Jan-15 | 54.92 | 56.43 | 56.55 | 53.71 |
| Jan-16 | 56.40 | 55.99 | 56.86 | 55.48 |
| Jan-20 | 54.72 | 55.69 | 55.88 | 54.00 |
| Jan-21 | 55.70 | 55.41 | 56.99 | 54.77 |
| Jan-22 | 55.56 | 54.95 | 56.70 | 54.08 |
Crinetics Pharmaceuticals, Inc. Earnings
Crinetics Pharmaceuticals, Inc. Earnings Report: Per Share Crinetics Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Crinetics Pharmaceuticals, Inc. Forecast Revenue Growth
Crinetics Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Crinetics Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $1.55 per share.
* Crinetics Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.